Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases
- 1 May 2018
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 189, 65-70
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Long-term Use of Autologous Serum 50% Eye Drops for the Treatment of Dry Eye DiseaseCornea, 2014
- The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover studyGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- Dry Eye Disease and Work Productivity Loss in Visual Display Users: The Osaka StudyAmerican Journal of Ophthalmology, 2014
- Autologous serum for ocular surface diseasesArquivos Brasileiros de Oftalmologia, 2008
- Allogeneic Serum Eye Drops for the Treatment of Severe Dry Eye in Patients With Chronic Graft-Versus-Host DiseaseCornea, 2007
- Comparison of Autologous Serum and Umbilical Cord Serum Eye Drops for Dry Eye SyndromeAmerican Journal of Ophthalmology, 2007
- Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studiesBritish Journal of Ophthalmology, 2001
- Reliability and Validity of the Ocular Surface Disease IndexArchives of Ophthalmology (1950), 2000
- Treatment of dry eye by autologous serum application in Sjogren's syndromeBritish Journal of Ophthalmology, 1999
- Immunoglobulin Deposition in the Cornea After Application of Autologous SerumArchives of Ophthalmology (1950), 1988